id: treatment_response_biomarkers_to_relapse_prevention
name: Biomarkers of AUD Treatment Response â†’ AUD Relapse Prevention
from_node:
  node_id: treatment_response_biomarkers
  node_name: Biomarkers of AUD Treatment Response
to_node:
  node_id: relapse_prevention
  node_name: AUD Relapse Prevention
direction: positive
category: healthcare_access
mechanism_pathway:
- 'Step 1: Molecular biomarkers enable prognosis of treatment response and relapse
  risk in AUD patients'
- 'Step 2: Early identification of non-responders or high-relapse-risk patients allows
  clinical intervention adjustments'
- 'Step 3: Healthcare providers can intensify psychosocial support or modify pharmacotherapy
  based on biomarker data'
- 'Step 4: Proactive treatment modifications reduce relapse rates and improve long-term
  recovery outcomes'
evidence:
  quality_rating: C
  n_studies: 1
  primary_citation: Laura B Ferguson et al. 2022. "RNA biomarkers for alcohol use
    disorder.." *Frontiers in molecular neuroscience*. https://doi.org/10.3389/fnmol.2022.1032362
last_updated: '2025-12-02'
version: '1.0'
llm_metadata:
  extracted_by: claude-sonnet-4-5-20250929
  extraction_date: '2025-12-02T18:12:06.673801'
  batch_id: msgbatch_01AKnPJgzm7Fk9qubgAz9GaD
moderators:
- name: comorbid_psychiatric_conditions
  direction: strengthens
  strength: moderate
  description: Biomarkers may be particularly valuable for patients with comorbid
    depression and anxiety, who have more complex treatment needs
_source_file: /Users/mauriceelhelou/Library/CloudStorage/OneDrive-HarvardUniversity/New
  folder (2)/healthsystems/mechanism-bank/mechanisms/healthcare_access/treatment_response_biomarkers_to_relapse_prevention.yaml
_category: healthcare_access
